BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 21084751)

  • 21. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
    Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
    Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importin-alpha protein binding to a nuclear localization signal of carbohydrate response element-binding protein (ChREBP).
    Ge Q; Nakagawa T; Wynn RM; Chook YM; Miller BC; Uyeda K
    J Biol Chem; 2011 Aug; 286(32):28119-27. PubMed ID: 21665952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.
    Bindesbøll C; Fan Q; Nørgaard RC; MacPherson L; Ruan HB; Wu J; Pedersen TÅ; Steffensen KR; Yang X; Matthews J; Mandrup S; Nebb HI; Grønning-Wang LM
    J Lipid Res; 2015 Apr; 56(4):771-85. PubMed ID: 25724563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
    Iizuka K; Horikawa Y
    Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload.
    Agius L
    Biochem Pharmacol; 2013 Feb; 85(3):306-12. PubMed ID: 23022226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein.
    Kawaguchi T; Takenoshita M; Kabashima T; Uyeda K
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13710-5. PubMed ID: 11698644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
    Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
    Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.
    Hanse EA; Mashek DG; Becker JR; Solmonson AD; Mullany LK; Mashek MT; Towle HC; Chau AT; Albrecht JH
    Cell Cycle; 2012 Jul; 11(14):2681-90. PubMed ID: 22751438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes.
    Stoeckman AK; Ma L; Towle HC
    J Biol Chem; 2004 Apr; 279(15):15662-9. PubMed ID: 14742444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.
    Jois T; Howard V; Youngs K; Cowley MA; Sleeman MW
    PLoS One; 2016; 11(12):e0168797. PubMed ID: 27992582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1.
    Zhu C; Huang M; Kim HG; Chowdhury K; Gao J; Liu S; Wan J; Wei L; Dong XC
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166249. PubMed ID: 34425214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
    Herman MA; Peroni OD; Villoria J; Schön MR; Abumrad NA; Blüher M; Klein S; Kahn BB
    Nature; 2012 Apr; 484(7394):333-8. PubMed ID: 22466288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells.
    Cha-Molstad H; Saxena G; Chen J; Shalev A
    J Biol Chem; 2009 Jun; 284(25):16898-16905. PubMed ID: 19411249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression.
    Villanueva-Ortega E; Méndez-García LA; Garibay-Nieto GN; Laresgoiti-Servitje E; Medina-Bravo P; Olivos-García A; Muñoz-Ortega MH; Ventura-Juárez J; Escobedo G
    Growth Horm IGF Res; 2020; 53-54():101332. PubMed ID: 32698101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.
    Denechaud PD; Bossard P; Lobaccaro JM; Millatt L; Staels B; Girard J; Postic C
    J Clin Invest; 2008 Mar; 118(3):956-64. PubMed ID: 18292813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
    Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
    J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes.
    Muraoka M; Fukushima A; Viengchareun S; Lombès M; Kishi F; Miyauchi A; Kanematsu M; Doi J; Kajimura J; Nakai R; Uebi T; Okamoto M; Takemori H
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1430-9. PubMed ID: 19351809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
    Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
    Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.